Equities

Helius Medical Technologies Inc

Helius Medical Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.8158
  • Today's Change-0.010 / -1.18%
  • Shares traded39.96k
  • 1 Year change-90.49%
  • Beta1.6219
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Helius Medical Technologies Inc had revenues fall -18.17% from 787.00k to 644.00k, though the company grew net income from a loss of 14.07m to a smaller loss of 8.85m.
Gross margin12.79%
Net profit margin-1,487.54%
Operating margin-2,034.51%
Return on assets-90.17%
Return on equity-161.97%
Return on investment-110.33%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Helius Medical Technologies Inc fell by 9.37m. Cash Flow from Financing totalled 1.08m or 167.24% of revenues. In addition the company used 10.42m for operations while cash used for investing totalled 29.00k.
Cash flow per share-7.42
Price/Cash flow per share--
Book value per share1.98
Tangible book value per share1.98
More ▼

Balance sheet in USDView more

Helius Medical Technologies Inc uses little or no debt in its capital structure.
Current ratio4.20
Quick ratio3.80
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.